![]() |
市場調查報告書
商品編碼
2080352
動物保健市場:2026-2032年全球市場預測(按動物類型、產品、治療應用、分銷管道和最終用戶分類)Animal Health Market by Animal Type, Product, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,動物保健市場規模將達到 1,358.4 億美元,年複合成長率為 8.58%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 763.1億美元 |
| 預計年份:2026年 | 827.5億美元 |
| 預測年份:2032年 | 1358.4億美元 |
| 複合年成長率 (%) | 8.58% |
動物健康已成為食品安全、公共衛生、伴侶動物照護、動物福利和國際貿易等各個領域的策略重點。根據世界動物衛生組織(WHO)、聯合國糧食及農業組織(FAO)、世界衛生組織(WHO)、美國食品藥物管理局管理局(FDA)、歐洲藥品管理局(EMA)、美國農業部(USDA)以及各國檢驗指南發布的權威指南,疾病預防、疫苗接種、診斷、合理使用抗生素和生物安全已成為建構穩健動物健康體系的核心要素。
由於疾病監測力度加大、抗生素使用管控更加嚴格以及對預防醫學投入的增加,動物健康領域的格局正在轉變。美國和歐盟的法規結構正在加強獸醫對具有重要醫療價值的抗生素的監管,而世界動物衛生組織(WOAH)的標準則繼續影響與生物安全、疾病報告和貿易相關的國際動物衛生要求。
人工智慧 (AI) 正在獸醫影像、病理支援、疾病預測、藥物安全監測、臨床工作流程自動化和牲畜監測等領域創造累積價值。 AI 工具能夠幫助臨床醫生識別 X 光、實驗室結果、電子健康記錄和穿戴式裝置資料中的模式,並在與臨床證據檢驗後,有助於改善分診和決策支援。
亞太市場正因中國、印度、日本、澳洲、韓國和東南亞國家畜牧業的大規模成長、水產養殖業的蓬勃發展、寵物消費支出的增加以及對疾病防治的持續重視而不斷擴張。北美地區仍然是動物健康領域的高價值市場,這得益於其先進的獸醫基礎設施、廣泛的寵物保險、生技藥品的創新、診斷能力以及對寵物和食用動物整體護理的嚴格抗菌藥物監管。
東協對動物健康的需求主要受家禽、生豬、水產養殖和伴侶動物產業成長的驅動,疾病管制對於糧食安全、持續出口和生物安全管理至關重要。海灣合作理事會(GCC)將糧食安全、駱駝和反芻動物健康、牲畜進口管制以及都市區伴侶動物市場的高品質獸醫服務列為優先事項,這體現了該地區對建立韌性供應鏈和預防醫學的重視。
美國在獸用生技藥品、伴侶動物服務、診斷技術、寵物保險和監管現代化方面處於主導。而加拿大則著重於監測、食品安全、合理使用抗菌藥物和畜牧健康計畫。墨西哥和巴西仍然是重要的畜牧市場;墨西哥與北美動物蛋白貿易聯繫緊密,而巴西則具有重要影響力,尤其是在牛肉和家禽出口、疫苗接種和畜牧健康管理方面。
產業領導者應優先發展預防性醫療保健產品線,包括疫苗、診斷試劑、驅蟲藥、生物安全解決方案和疾病監測工具。商業策略必須與基於證據的療效聲明一致,並符合合理使用抗生素、獸醫主導的護理、動物福利以及監管和藥物安全監測標準的要求。
本執行摘要基於權威機構(包括世界動物衛生組織 (WOAH)、聯合國檢驗(FAO)、世界衛生組織 (WHO)、經濟合作暨發展組織 (OECD)、美國食品藥品監督管理局 (FDA)、美國農業部 (USDA)、歐洲藥品管理局 (EMA)、歐洲疾病預防控制中心 (ECDC)、歐洲食品安全局 (USDA)、歐洲藥品管理局 (EMA)、歐洲疾病預防控制中心 (ECDC)、歐洲食品安全局 (EFSA) 以及透過各機構的二手研究機構本分析重點檢驗的監管趨勢、疾病控制重點、合理的抗菌藥物使用措施、已證實的生產趨勢以及實證動物健康促進措施。
動物健康管理正朝著預防、監測、合理利用和運用數位科技的獸醫學方向發展。這一領域的成長動能與寵物「人性化」、畜牧業生產力提升、水產養殖業發展、食品安全、疾病防治以及全球「同一健康」議程密切相關。
The Animal Health Market is projected to grow by USD 135.84 billion at a CAGR of 8.58% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 76.31 billion |
| Estimated Year [2026] | USD 82.75 billion |
| Forecast Year [2032] | USD 135.84 billion |
| CAGR (%) | 8.58% |
Animal health has become a strategic priority across food security, public health, companion animal care, animal welfare, and global trade. Verified guidance from WOAH, FAO, WHO, FDA, EMA, USDA, and national veterinary authorities shows that disease prevention, vaccination, diagnostics, responsible antimicrobial use, and biosecurity are now central to resilient animal health systems.
Demand is being shaped by rising pet ownership, higher animal protein consumption, intensified livestock production, aquaculture expansion, and greater awareness of zoonotic disease risks. The sector is moving from reactive treatment to preventive, data-enabled veterinary care that supports One Health outcomes across animals, people, and ecosystems.
The animal health landscape is being transformed by stronger disease surveillance, tighter antimicrobial stewardship, and growing investment in preventive care. Regulatory frameworks in the United States and European Union have increased veterinary oversight of medically important antimicrobials, while WOAH standards continue to shape international biosecurity, disease notification, and trade-related animal health requirements.
At the same time, veterinary clinics, livestock producers, and animal health manufacturers are adopting connected diagnostics, cold-chain improvements, telehealth tools, and precision herd management. These shifts are increasing demand for vaccines, parasiticides, diagnostics, nutrition-linked health solutions, pharmacovigilance systems, and digital veterinary platforms that improve clinical decision-making and disease preparedness.
Artificial intelligence is creating cumulative value across veterinary imaging, pathology support, disease forecasting, pharmacovigilance, clinic workflow automation, and livestock monitoring. AI-enabled tools can help clinicians identify patterns in radiographs, laboratory results, electronic medical records, and wearable data, improving triage and decision support when validated against clinical evidence.
In production animal health, AI supports early detection of lameness, respiratory disease, mastitis risk, heat stress, abnormal behavior, and feed efficiency issues. Its impact is strongest when combined with veterinary oversight, high-quality datasets, transparent validation, cybersecurity controls, and compliance with data privacy, animal welfare, and medical device expectations.
Asia-Pacific is expanding through large livestock populations, aquaculture growth, rising companion animal spending, and continued disease-control priorities in China, India, Japan, Australia, South Korea, and Southeast Asian economies. North America remains a high-value animal health region supported by advanced veterinary infrastructure, pet insurance adoption, biologics innovation, diagnostic capacity, and strict antimicrobial oversight across companion animal and food animal care.
Latin America benefits from Brazil and Mexico's export-oriented livestock systems, vaccination programs, and growing demand for poultry, cattle, and companion animal health solutions. Europe is shaped by EU animal health law, sustainability policy, veterinary pharmacovigilance, animal welfare standards, and coordinated antimicrobial stewardship. The Middle East is investing in food security, import controls, camel and ruminant health, and modern veterinary services, while Africa remains focused on vaccination access, transboundary disease control, zoonotic disease surveillance, and the expansion of veterinary infrastructure.
ASEAN animal health demand is supported by poultry, swine, aquaculture, and companion animal growth, with disease control remaining essential for food security, export continuity, and biosecurity management. The GCC is prioritizing food security, camel and ruminant health, livestock import controls, and high-quality veterinary services in urban companion animal markets, reflecting the region's focus on resilient supply chains and preventive care.
The European Union leads on antimicrobial stewardship, animal welfare, pharmacovigilance, and regulatory harmonization under a coordinated animal health framework. BRICS economies combine large livestock bases, expanding aquaculture, zoonotic disease priorities, and rising pet care expenditure, while G7 markets drive innovation in biologics, diagnostics, veterinary services, digital health, and advanced regulatory compliance. NATO members increasingly view biosecurity, veterinary readiness, and protection of food systems as part of broader resilience planning.
The United States leads in veterinary biologics, companion animal services, diagnostics, pet insurance adoption, and regulatory modernization, while Canada emphasizes surveillance, food safety, antimicrobial stewardship, and livestock health programs. Mexico and Brazil remain important livestock markets, with Mexico linked closely to North American animal protein trade and Brazil especially influential in beef and poultry exports, vaccination, and herd health management.
The United Kingdom, Germany, France, Italy, and Spain combine mature veterinary networks with EU or aligned animal welfare, pharmacovigilance, and antimicrobial stewardship standards, while Russia maintains demand across livestock productivity, disease prevention, and companion care. China and India offer scale in production animals, aquaculture, vaccines, and pets; Japan, Australia, and South Korea emphasize premium companion animal care, biosecurity, diagnostics, preventive medicine, and advanced companion animal therapeutics.
Industry leaders should prioritize preventive health portfolios, including vaccines, diagnostics, parasiticides, biosecurity solutions, and disease monitoring tools. Commercial strategies should align with antimicrobial stewardship, veterinarian-led care, animal welfare expectations, and evidence-based claims that meet regulatory and pharmacovigilance requirements.
Organizations should also invest in regional manufacturing resilience, cold-chain reliability, supply-chain visibility, digital adoption, and partnerships with clinics, producers, universities, laboratories, and public agencies. AI initiatives must be clinically validated, explainable, secure, and integrated into veterinary workflows rather than positioned as replacements for professional judgment.
This executive summary is based on triangulated secondary research from authoritative organizations, including WOAH, FAO, WHO, OECD, FDA, USDA, EMA, ECDC, EFSA, and national veterinary and agriculture agencies. The analysis emphasizes verified regulatory developments, disease-control priorities, antimicrobial stewardship policies, documented production trends, and evidence-based animal health drivers.
The assessment combines policy review, value-chain mapping, product category analysis, regional benchmarking, disease surveillance interpretation, and validation against publicly available clinical, trade, and regulatory evidence. Qualitative insights are framed conservatively to avoid unsupported market-size, market-share, or growth-rate claims.
Animal health is moving toward prevention, surveillance, stewardship, and digitally enabled veterinary care. The sector's momentum is linked to pet humanization, livestock productivity, aquaculture growth, food safety, disease preparedness, and the global One Health agenda.
Organizations that combine scientific credibility, regulatory discipline, access-focused distribution, resilient supply chains, and responsible AI adoption will be best positioned. Long-term success will depend on delivering measurable animal welfare, veterinary efficiency, public health, food security, and producer productivity outcomes.